Palvella Therapeutics's total assets for Q2 2025 were $73.75M, a decrease of -7.17% from the previous quarter. PVLA total liabilities were $25.97M for the fiscal quarter, a 8.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.